Print Page  |  Close Window


Corporate Profile

LabCorp (NYSE: LH), an S&P 500 company, is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster and uses technology to improve the delivery of care. LabCorp reported net revenues of over $10 billion in ... Read More >>

Upcoming Events

Thursday, July 25, 2019 9:00 a.m. ET

Q2 2019 Laboratory Corporation of America Holdings Earnings Conference Call

Recent News


LabCorp to Announce Second Quarter Financial Results on July 25, 2019


LabCorp and Mount Sinai Health System Collaborate to Establish Digital and AI-Enabled Pathology Center of Excellence


LabCorp and QIAGEN Announce New therascreen PIK3CA Mutation Analysis Companion Diagnostic for Metastatic Breast Cancer

Click Here to view additional press releases

LH (Common)
Change Stock is Down 1.24
Data as of 06/26/19 4:00 p.m. ET
Refresh quote
Data provided by Nasdaq. Minimum 15 minutes delayed.